SIRT1 and diabetic kidney disease: Specifically, SIRT1 mediates the dephosphorylation and deacetylation of p65 NF-κB and STAT3, thereby attenuating inflammation, oxidative stress, and EMT in diabetic kidney disease (DKD) (37).